Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Agree our "global pharma partner" is NOT Apotex, it is a
View:
Post by subaru1i on Dec 18, 2023 2:33pm

Agree our "global pharma partner" is NOT Apotex, it is a

U.S. based pharmaceutical 'traditional global pharma partner' because the New Drug Application was submitted to the FDA where as Apotex a Canadian company would have made their submission to Health Canada.   So who are biggest U.S. based 'traditional global pharma' companies?  2 names, Pfizer and J & J...so pick one and be happy.
Comment by mdjbrown on Dec 18, 2023 7:44pm
s1i, I still think Medipharms generic global pharma partner is likely Apotex as per the ANDA + paragraph IV filed with the FDA in late Nov 2022 to challenge Jazz Epidiolex 303 patent. One thing for sure is Labs partner will be one of the defendants named in the Epidiolex lawsuit. In partnership with a large global pharmaceutical company, in 2022 MediPharm contributed active ...more  
Comment by subaru1i on Dec 18, 2023 8:05pm
My point of fact was strictly w.r.t. the NDA and not of the ANDA.  Apotex could be perhaps the 'generic' partner relative to legal matters at hand involving the generic of Epidiolex and recent Health Canada approval of Epidiolex in Canada.   The NDA being filed in country of jurisdiction, with the FDA and hence the "traditiional global pharmaceutical partner" that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities